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CLINICAL REPORT
Acta Derm Venereol 2007; 87: 43–48
Only a few studies, conducted in Sweden, assessed fac-
tors associated with the presence of atypical moles in the 
general population. We conducted a population-based, 
case-control study in New Hampshire, USA, to identify 
factors associated with atypical moles. In our study, atypical 
moles affected 14% of the study population. The adjusted 
odds ratio (OR) was 0.34 (95% confidence interval 
(CI) = 0.14–0.80) for those with the highest adulthood re-
creational sun exposure, relative to the lowest. The OR for 
any freckles, compared to none, was 2.24 (95% CI = 1.18–
4.25). We found a linear relationship between the number 
of benign moles and the presence of atypical moles (p for 
trend = 0.0001). The OR was 7.34 (95% CI = 3.03–17.80) 
for > 15 benign moles, relative to 0–4. Our data indicate 
that freckles and benign moles, which may reflect mela-
nocytic inducibility, are strongly associated with atypical 
moles. The inverse association with sun exposure should 
be considered with caution. Key words: moles; atypical 
moles; pigmentary characteristics; sun exposure.
(Accepted September 21, 2006.)
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Numerous epidemiological studies (1–9), including 2 
population-based case-control studies, one in Sweden 
(10), and another in the USA (11), have shown that 
34–56% of melanoma patients have clinically atypical 
moles, or evidence of histologically atypical moles. In 
addition to the epidemiological evidence, pathology 
studies indicate that about half of melanomas arise in 
histological contiguity with an atypical mole (12–14). 
Considered collectively, the evidence to date suggests 
that atypical moles are strong risk factors and potential 
precursors of melanoma (reviewed in 15). 
Because atypical moles are strongly associated with 
risk of melanoma (1–11), and risk of second primary 
melanoma (16–19), prevention of the precursor offers 
a strategy for reducing melanoma incidence and bur-
den. To date, several studies have attempted to identify 
risk factors for atypical moles (20–32), but most were 
limited to the assessment of host characteristics. Several 
studies used indirect measures of sun exposure (22, 24, 
29, 31, 32) including a study of children (27); only a 
few directly assessed sun exposure histories (23–26, 
30), and only one of these studies, conducted in Sweden, 
was population-based (26). 
We conducted a population-based study of risk factors 
for atypical moles. Host characteristics and complete histo-
ries of sunburn and sun exposure were obtained by a tele-
phone interview. Benign and clinically atypical moles were 
assessed in a physician-conducted skin examination.
METHODS
This study was approved by the Committee for the Protection 
of Human Subjects at Dartmouth College. All study participants 
gave verbal consent (for interview) and signed consent (for 
skin examination).
The study population consists of controls who participated 
in a population-based, case-control study of melanoma (11). 
The parent study was designed to over-sample controls to 
allow an embedded study of atypical moles within the control 
series. Controls of ages 20–69 years were ascertained through 
the New Hampshire Department of Motor Vehicles using 
drivers’ license lists available between January 1995 and 
December 1998. Eligibility required current residence in New 
Hampshire, a working telephone number, and ability to partici-
pate in an English-speaking interview. A letter introducing the 
study was sent to potential participants, followed by a telephone 
call from the interviewer. We enrolled 684 of 1121 (61%) poten-
tially eligible control subjects; 87 (8%) could not be reached, 
13 (1%) had died, and 337 (30%) declined to participate. Of 
the 684 control participants, 6 were deemed ineligible due to a 
prior diagnosis of melanoma, leaving 678 eligible controls for 
the present analysis. 
The 40-min telephone interview queried participants for 
demographic factors, family history of melanoma, pigmentary 
characteristics, sun sensitivity, episodes of sunburn, hours 
of sunbathing, and hours of recreational and occupational 
sun exposure. Pigmentary characteristics included hair color 
(black/dark brown, brown, light brown/red-brown, blond/red) 
eye color (brown, gray/green/hazel, blue), and the presence of 
freckles (none, any). Sun sensitivity was assessed by asking 
subjects how their skin would react if exposed for 1 h to strong 
summer sunlight; answer options included sunburn with peeling 
followed by no tan or a light tan; sunburn with peeling followed 
by freckles; sunburn followed by tan, and immediate tanning.
A detailed description of the sun-related variables has been 
published previously (11). Briefly, we asked participants 
about episodes of sunburn with peeling, and separately about 
sunburn with blistering, in 10-year age periods, starting at age 
10 years. Questions regarding sun exposure included hours of 
sunbathing (asked in 10-year age intervals starting at age 10 
years), hours of outdoor recreational sun exposure (starting at 
Factors Associated with Atypical Moles in New Hampshire, USA
Linda TITUS-ErNSTOFF1, Jiao DINg1, Ann E. PErry2, Steven K. SPENCEr3, Bernard F. COLE1 and Marc S. ErNSTOFF3
1Department of Community and Family Medicine, Dartmouth Medical School, and the Norris Cotton Cancer Center, and Departments of 2Pathology and 
3Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, USA
44 L. Titus-Ernstoff et al.
age 10 years), and hours of occupational exposure during the 
summer (starting at age 6 years to accommodate farm work). 
For the 3 sun exposure variables (sunbathing, recreational, 
and occupational sun exposure), daily exposure was capped 
at 10 h. Each of these variables was evaluated separately as 
the number of hours of sun exposure occurring prior to age 20 
years, at age 20 years or more, and in total over the lifetime. 
Sun exposure was assessed prior to a reference date, which had 
been assigned to the controls at random to correspond to one 
year prior to the melanoma diagnosis date of cases participating 
in the parent study. 
At the conclusion of the interview, participants were invited 
to undergo a dermatologist-conducted study-related skin exami-
nation during which the number and site of benign and atypical 
moles were recorded using a standardized form. The skin exa-
mination covered all skin areas other than the anogenital area. 
To help distinguish benign moles from lentigines, diagnostic 
criteria included palpability and a diameter of at least 3 mm 
(1). Additional diagnostic criteria for benign moles included a 
symmetrical shape, well-defined border, and uniform coloration 
(1). A mole was considered atypical if it met at least 3 of the 
following criteria: diameter of 5 mm or more, flat (macular) 
component, erythema, irregular border, ill-defined border, and 
variegated color (18). 
Of the 678 eligible controls, 424 (63%) participated in the skin 
examination, which identified 59 participants with clinical evi-
dence of at least one atypical mole and 365 participants without 
atypical moles. For the purposes of the present analyses, we clas-
sified those with clinical evidence of at least one atypical mole as 
“cases,” and those without an atypical mole as “controls.”
Preliminary analyses included frequency distributions and 
descriptive statistics. When possible, sun-related variables were 
assessed using zero as the reference level; when this was impracti-
cal (due to small numbers), the data were assessed in approximate 
tertiles, based on the distribution in the controls. Odds ratios 
(OR) and 95% confidence intervals (CI) were computed using 
multivariable logistic regression models (33) to assess the asso-
ciation between risk factors and atypical moles. Initially, factors 
were evaluated singly in models that included terms for age and 
gender. Multivariable models were used to assess variables that 
were significantly (p < 0.05; two-sided) associated with atypical 
moles in the age and gender adjusted analyses. 
rESULTS
In our study population, 59 (14%) individuals had at 
least one atypical mole; 24 (40.7%) affected individuals 
had only one atypical mole, 18 (30.5%) had 2–3, and 
17 (28.8%) had ≥ 4. Among those with any atypical 
moles, the mean count was 4.2 (median = 2). Fifty-two 
(88.1%) affected individuals had at least one atypical 
mole on the trunk, and most of the trunk lesions (84.6%) 
were located on the back or shoulders. 
The initial age-and-gender adjusted models indicated 
that the odds of having at least one clinically atypical 
mole were significantly decreased in the older age groups, 
compared to the youngest (Table I). Atypical moles 
were also observed significantly less often in women, 
compared to men. The data suggested possible slight as-
sociations with level of education and a family history of 
melanoma, but the findings were compatible with chance 
(data not shown). Freckles were associated with a near 
doubling of the odds of having atypical moles. 
Based on the cut-points shown, the odds of an atypical 
mole increased markedly with the number of benign 
moles. The elevated Ors corresponding to hair and 
eye color were not statistically significant, and did not 
increase consistently with lighter eye or hair color (data 
not shown). The Ors also did not appear to increase 
with greater sun sensitivity, but the data indicated an 
association with the tendency to tan following sunburn, 
compared to those who burned and peeled (Table I). The 
age-and-gender adjusted models provided little evidence 
of a positive association with any of the sun exposure 
variables (data not shown). If anything, the results 
suggested inverse associations with most measures of 
sunburn or sun exposure, whether before age 20 years, 
age 20 years or older, or in total over the lifetime. A 
significant inverse association was noted for the highest 
level of hours of adulthood recreational sun exposure, 
compared to the lowest (Table I).
In a multivariable model, the variables age, gender, 
freckles, recreational sun exposure at age 20 years or 
more, and number of benign moles were significantly as-
sociated with the presence of at least one atypical mole. 
Sun sensitivity did not retain a significant association, 
and was omitted from the final multivariable model. 
As age increased, the tendency to have atypical moles 
decreased, an inverse association that was statistically 
Table I. Number (%) of cases and controls according to select 
characteristics and odds ratios (OR) and 95% confidence intervals 
(CI) for having at least one clinically atypical mole
Characteristics Cases 
n = 59
n (%)
Control 
n = 365
n (%)
Ora 95% CI
Age group (years)
≤ 39 17 (28.8) 47 (12.9) 1.00 –
40–59 33 (55.9) 182 (49.9) 0.46 0.23–0.91
≥ 60 9 (15.3) 136 (37.3) 0.16 0.07–0.40
gender
Male 38 (64.4) 216 (59.2) 1.00 –
Female 21 (35.6) 149 (40.8) 0.43 0.22–0.86
Freckles 
No 19 (32.8) 171 (48.3) 1.00 –
yes 39 (67.2) 183 (51.7) 1.87 1.03–3.41
Benign nevi
0–4 15 (25.4) 227 (62.2) 1.00 –
5–14 29 (49.2) 110 (30.1) 3.51 1.79–6.87
≥ 15 15 (25.4) 28 (7.7) 7.44 3.25–17.06
Sun sensitivity
Burn, peel 20 (33.9) 164 (44.9) 1.00 –
Burn, freckle 3 (5.1) 24 (6.6) 1.02 0.28–3.76
Burn followed by tan 34 (57.6) 141 (38.6) 1.93 1.05–3.54
Tan only 2 (3.4) 36 (9.9) 0.45 0.10–2.05
recreational hours age  ≥ 20 years
0–3300 24 (41.4) 115 (32.1) 1.00 –
3301–9000 24 (41.4) 114 (31.8) 0.96 0.51–1.81
9001+ 10 (17.2) 129 (36.0) 0.40 0.18–0.90
aOr for age adjusted for gender, Or for gender adjusted for age. All other 
Ors adjusted for age and gender. Variations in column totals are due to 
missing valves.
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significant (p for trend = 0.001) (Table II). relative to 
those of age 39 years or less, the odds of having an 
atypical mole were reduced by nearly half for those of 
ages 40 to 59 years (Or = 0.52; 95% CI = 0.24–1.13), 
and by more than 70% in those of age 60 years or more 
(Or = 0.26; 95% CI = 0.10–0.69). gender remained 
strongly associated with having an atypical mole, and 
the odds of having an atypical mole were more than 
halved for women, relative to men (Or = 0.44; 95% 
CI = 0.22–0.87). The presence of freckles more than 
doubled the odds of having an atypical mole (Or = 2.24; 
95% CI = 1.18–4.25). We found no evidence that ex-
posure to intermediate recreational sun exposure in 
adulthood was associated with an atypical mole, but 
the Or was 0.34 (95% CI = 0.14–0.80) for those with 
the highest amount of exposure, relative to the least. 
The data indicated a positive association between the 
number of benign moles and having an atypical mole (p 
for trend < 0.0001). The fully adjusted Ors were 3.74 
(95% CI = 1.86–7.51) for those with 5–14 moles, and 
7.34 (95% CI = 3.03–17.80) for those with at least 15 
moles, relative to 0–4 benign moles. 
The average number of benign moles was 7 overall, 
13 in cases with atypical moles, and 6 in controls. Table 
III shows the number of benign moles (0–14; ≥ 15), and 
the mean number of benign moles, by age group (< 50, 
≥ 50) and by gender in cases and controls. Based on 
the cut-points shown, a larger proportion of cases than 
controls had high (≥ 15) benign mole counts, but within 
the case and control groups, the proportion affected by 
high mole counts was similar for the younger and older 
individuals. Similarly, the mean number of benign moles 
(in those with at least one) was about doubled in cases 
compared to controls, but within the case and control 
groups, the mean number of benign moles was similar 
by age group. 
In the case group, a larger proportion of women than 
men had high counts of benign moles, but the proportions 
were more similar for men and women in the control 
group. For both men and women, the mean number of 
benign moles was roughly doubled in cases, compared 
to controls, but within the case and control groups, the 
mean counts were similar for men and women.
DISCUSSION
To our knowledge, this is the first report of sun ex-
posures and host characteristics, including benign 
moles, in relation to atypical moles in a geographically 
defined population in the USA. Our data indicate that 
about 14% of individuals in the non-melanoma study 
population were affected by at least one clinically 
atypical mole, an estimate within the bounds sug-
gested by previous studies. Estimates of atypical mole 
prevalence based on previous studies vary as much as 
9-fold, perhaps reflecting differences in the ages of 
study participants, population differences in suscepti-
bility, and/or participation bias associated with referral 
patterns. Clinic-based studies in the USA indicate that 
7–17% of controls have at least one atypical mole (2, 3, 
8), those in Europe report a prevalence of 2–18% (4, 7, 
32, 34, 35), and studies in Australia show a prevalence 
Table II. Factors associated with having at least one clinically atypical mole
risk factor Or (95% CI)a
Ageb (years)
≤ 39 1.00 
40–59 0.52 (0.24–1.13)
≥ 60 0.26 (0.10–0.69)
gender
Male 1.00 
Female 0.44 (0.22–0.87)
Freckles
None 1.00 
Any 2.24 (1.18–4.25)
Recreation hours, age ≥ 20 years 
0–3300 1.00
3301–9000 1.01 (0.50–2.03)
≥ 9001 0.34 (0.14–0.80)
Benign molesc
0–4 1.00 
5–14 3.74 (1.86–7.51)
≥ 15 7.34 (3.03–17.80)
aOr for age was adjusted for gender; Or for gender was adjusted for age. 
Other Ors adjusted for all variables in the table.
bp for trend (continuous form of the variable) = 0.001.
cp for trend (continuous form of the variable) < 0.0001.
Table III. The number (%) of subjects with benign moles, and the mean number of benign molesa, by age group and gender in cases and 
controls
No. of benign moles
Cases (n = 59) Controls (n = 365)
0–14 ≥ 15 Mean (SE) 0–14 ≥ 15 Mean (SE)
Age (years)
< 50 20 (74.1) 7 (25.9) 13.8 (2.2) 101 (90.9) 10 (9.1) 6.6 (0.8)
≥ 50 24 (75.0) 8 (25.0) 11.7 (1.7) 236 (92.9) 18 (7.1) 5.7 (0.4)
gender
Male 30 (78.9) 8 (21.1) 12.3 (1.8) 201 (93.1) 15 (6.9) 6.1 (0.5)
Female 14 (66.7) 7 (33.3) 13.2 (2.2) 136 (91.3) 13 (8.7) 5.8 (0.5)
aMean counts are based on those with at least one benign mole.
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of 6–22% (6, 32). Variation also exists in reports from 
population-based studies; a study in Israel indicated 
that only 2.5% of men had atypical moles (36), whereas 
2 studies in Sweden reported a prevalence of 11% (30) 
and 18% (28), respectively. 
Our finding of a strong association between having 
atypical moles and counts of benign moles is consistent 
with a clinic-based investigation (35) and the popula-
tion-based studies in Sweden (26, 28, 30). Consistent 
with previous reports, women were less likely than men 
to be affected by atypical moles (23), as were older in-
dividuals (21, 23). The strong association observed here 
between age and atypical mole counts was not found 
in the Swedish study (28), perhaps because enrollment 
was limited to individuals of ages 30–50 years. In our 
data, benign mole counts were substantially lower than 
observed in the control series of clinic-based melanoma 
case-control studies (2–5, 7), consistent with the pos-
sibility that mole counts are higher in clinic populations 
than in the general population. To the extent that benign 
mole development is influenced by sunlight (20, 29), 
the low mole counts in our study may also reflect the 
relatively northern latitude of New Hampshire (42º–45º), 
although high counts have been noted in Sweden (28). 
We counted moles that were of at least 3 mm diameter, 
whereas most studies counted lesions of at least 2 mm 
diameter, but this probably would not account for the 
magnitude of difference observed.
In our study, freckles were moderately associated 
with atypical moles. Our analyses were based on self-
reported freckling, so we cannot rule out the possibility 
that study participants confused atypical moles or solar 
lentigines for freckles. However, the association was 
also observed in a previous study in which both freckles 
and atypical moles were assessed by a physician (26). 
Freckles and benign moles may be lesions that signal 
individuals with increased melanocytic reactivity to 
sun exposure. 
Our data suggested a possible inverse association 
between sunburns and atypical moles, consistent with 
the lower sun exposure in the case group, but our find-
ings were not statistically significant. A previous study, 
conducted in Sweden showed a significant inverse as-
sociation between the number of sunburns and atypical 
moles (26), while other studies, including 2 suggesting 
positive effects (23, 25), produced findings consistent 
with chance (23–25, 30). 
The role of sun exposure in relation to atypical moles 
is also uncertain. Some studies using indirect measures 
of sun exposure supported an association between sun 
exposure and atypical moles (24, 29, 31, 32), but others 
did not (20, 35). Similarly, of the studies using direct 
measures of sun exposure, 2 reported null results (23, 
30), one suggested positive effects (26), and 2 more 
suggested inverse associations (24, 25), but all findings 
were consistent with chance (23–26, 30). The paucity 
of evidence supporting a positive association between 
sun exposure and atypical moles poses an interesting 
contrast with the established association between sun 
exposure and melanoma. Our study suggested inverse 
relationships between atypical moles and most measu-
res of sun exposure. Individuals with a susceptibility 
or tendency to develop moles or atypical moles might 
not require extensive sun exposure to develop these 
lesions (37). 
Although highly speculative, it is also conceivable 
that sun exposure is avoided by individuals whose 
experience indicates a tendency to develop atypical 
moles. To explore this possibility, we informally in-
spected shifts in hours of recreational sun exposure 
(which accounted for the majority of sun exposure) from 
childhood to adulthood. In cases with atypical moles, 
the proportion with the highest level of recreational sun 
exposure hours decreased from 33.9% in childhood to 
17.2% in adulthood. In contrast, in controls, the pro-
portion with the highest level of recreational sun hours 
increased slightly from 31.9% in childhood to 36.0% 
in adulthood. Thus, it is conceivable that individuals 
who develop melanocytic lesions reduce their sun 
exposure over time, a behavior that could account for 
the inverse association observed here between adult 
recreational sun exposure and atypical moles. In any 
case, due to the preliminary nature of this finding, and 
the uncertainty concerning biological mechanisms, our 
data should not be interpreted as suggesting that more 
extensive sun exposure will prevent the development 
of atypical moles. 
Because of the small size of our study, we were unable 
to detect modest associations, or to assess factors accord-
ing to the number or site of atypical moles. Most cases 
had at least 2 atypical moles, offering some assurance 
that they were correctly classified as cases, and that our 
findings are relevant to individuals with multiple atypi-
cal moles. Nearly all cases had at least one atypical mole 
on the trunk, so our results would almost certainly apply 
to this lesion site. Also, we designed a population-based 
study, but enrollment of non-melanoma participants, on 
which this report is based, was suboptimal, and those 
who self-selected for participation may not represent 
the underlying population. It is conceivable, for ex-
ample, that those with multiple or worrisome moles are 
over-represented in our study, which offered a no-cost, 
physician-conducted skin examination. If the factors 
influencing participation were also associated with 
measured exposures, our results may be biased. How-
ever, our findings are generally consistent with those of 
clinic-based studies, and with the few existing popula-
tion-based studies, arguing against bias. For example, 
the prevalence of atypical moles observed here (14%) 
is similar to that seen in 2 previous population-based 
studies (11% and 18%), in which participation was high 
(28, 30). Also, our findings with regard to the association 
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between benign and atypical moles are consistent with 
the small number of previous population-based studies, 
which were conducted in Sweden (26, 28, 30). 
In summary, our data indicate a strong association 
between atypical moles and benign moles, and a mode-
rately strong relationship with freckling, characteristics 
that may reflect melanocytic inducibility. Consistent 
with most previous studies, we found no evidence that 
sun exposure increases the odds of atypical moles. 
Although we noted an inverse association between 
atypical moles and the highest amount of total recrea-
tional sun exposure, further studies are needed to assess 
this relationship.
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